Aquablation treatment study for enlarged prostate in Canada
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial studies how well Aquablation works for men with an enlarged prostate (BPH) in Canada. You may be eligible if your clinician believes Aquablation is an appropriate treatment and you can complete the study visits and questionnaires.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a first-time diagnosis of enlarged prostate (BPH) (not another main prostate problem).
- You are a man age 18 or older.
- Your doctor/investigator has said Aquablation is a suitable treatment option for you.
- You’re willing and able to fill out study questionnaires accurately.
- You can sign and date the consent form to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at outcomes from the Rezūm procedure for men with an enlarged prostate (BPH). You may be asked to complete questionnaires and follow the study plan to help researchers understand how well this treatment works and is tolerated.
This study is a registry that collects information from men who have had or will have a procedure called Aquablation to treat an enlarged prostate. It helps doctors learn more about how well the treatment works in real life.
This trial tests a new device designed to treat symptoms of an enlarged prostate (BPH), such as frequent or difficult urination. It may help improve urine flow and reduce discomfort without traditional surgery.
This trial compares Aquablation with a laser procedure (HoLEP) to improve urinary symptoms caused by an enlarged, non-cancer prostate. It may help you understand which treatment works better for symptom relief in men with medium-to-large prostates.
This study tests whether giving a medicine called tranexamic acid before Aquablation surgery helps reduce bleeding during the procedure. The goal is to see if it makes the surgery safer and reduces blood loss for men with an enlarged prostate.
This study compares two ways of managing early-stage prostate cancer: active surveillance (regular monitoring) and surgery to remove the prostate. It aims to see which approach is better for men with low or intermediate risk prostate cancer.
Hear when a new Urologic Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.